Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Merck Develops First-in-Class WINREVAIR™ Treatment for Pulmonary Arterial Hypertension
Merck has developed WINREVAIR™ (sotatercept-csrk), a groundbreaking treatment designed for adults with pulmonary arterial hypertension (PAH). This medication aims to enhance exercise capacity, elevate WHO functional class
Mind Medicine Developed Novel MM120 for the Treatment of Anxiety Disorder
Mind Medicine has developed a groundbreaking treatment named MM120 for generalised anxiety disorder MM120 is administered in a single dose
UChicago Medicine Discovered First-of-its-kind Resmetirom Drug for Metabolic Liver Disease
The University of Chicago Medicine has unveiled a groundbreaking drug designed to tackle advanced metabolic dysfunction-associated steatotic liver disease
Celltrion Developed First-of-its-kind ZYMFENTRA™ for the Treatment of Crohn's Disease
Celltrion has developed first-of-its-kind ZYMFENTRA™, a pioneering subcutaneous formulation of infliximab.
Bristol Myers Squibb Introduced Breakthrough Breyanzi ® CAR T Cell Therapy
Bristol Myers Squibb has introduced Breyanzi® as the first CAR T cell therapy designed specifically for adults facing relapsed or refractory chronic lymphocytic leukaemia
Johnson & Johnson Discovered First-of-its-kind RYBREVANT® for the Treatment of Patients with Non-Small Cell Lung Cancer
Johnson & Johnson has introduced RYBREVANT® as a groundbreaking therapy for the initial treatment of individuals diagnosed with non-small cell lung cancer
Iovance Biotherapeutics Developed First-of-its-Kind AMTAGVI™ for Advanced Melanoma
Iovance Biotherapeutics has developed first-of-its-kind AMTAGVI™ cell therapy for a solid tumour cancer and first treatment option for advanced melanoma.
Bayer Introduces Breakthrough Therapy BAY 2927088 for Non-Small Cell Lung Cancer
Bayer has introduced a groundbreaking therapy named BAY 2927088 for addressing adult patients afflicted with unresectable or metastatic non-small cell lung cancer
Nuvalent Discovered Novel NVL-520 for the Treatment of Non-Small Cell Lung Cancer
Nuvalent has developed NVL-520, a new treatment for patients with ROS1-positive metastatic non-small cell lung cancer who have previously undergone treatment with two or more ROS1 tyrosine kinase inhibitors
Biogen Developed SKYCLARYS® (omaveloxolone), the First Therapy to treat Friedreich’s Ataxia
Biogen has developed SKYCLARYS®, marking a significant breakthrough as the inaugural therapeutic option for addressing Friedreich’s ataxia in adults and adolescents aged 16 years and older.
